GR
Geetha Reddy Channa
About Geetha Reddy Channa
Data last updated:
Geetha Reddy Channa is a Director at Nuevo Therapeutics Private Limited (since 2013). The company operates in Pharma. Nuevo Therapeutics Private Limited reported revenue of ₹1.11 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Nuevo Therapeutics Private Limited U24232TG2013PTC085338 | Director | 10 Jan 2013 | 2013 | ₹1.11 Cr (FY 2025) | Active |
Board colleagues of Geetha Reddy Channa
| Name | DIN | Company | Designation |
|---|---|---|---|
| Mitra Puchhalapalli | 00631734 | Nuevo Therapeutics Private Limited | Director |
| Priyatham Reddy Chennareddy | 06462285 | Nuevo Therapeutics Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Geetha Reddy Channa
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Geetha Reddy Channa
Geetha Reddy Channa currently holds 1 directorship: Nuevo Therapeutics Private Limited (Director, since 10 Jan 2013, revenue ₹1.11 Cr (FY 2025)).
Geetha Reddy Channa was first appointed on 10 Jan 2013 as Director at Nuevo Therapeutics Private Limited.
The current boards of Geetha Reddy Channa's companies include Mitra Puchhalapalli (Nuevo Therapeutics Private Limited), Priyatham Reddy Chennareddy (Nuevo Therapeutics Private Limited).